본문 바로가기
KERD
논문KCI 등재

Stimulating Effect of a Novel Synthesized Sulfonamido-Based Gallate ZXHA-TC on Primary Osteoblasts

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류의학일반

초록

Purpose: This study is intended to investigate the effects of plants or plant-derived antioxidants on prevention of osteoporosis through the maintenance of reactive oxygenspecies (ROS) at a favorable level. Materials and Methods: In this study, a novel antioxidant, namely 3,4,5-Trihydroxy-N-[4-(5-hydroxy-6-methoxy-pyrimidin-4-ylsulfamoyl)-phenyl]-benzamide (ZXHA-TC) was synthesized from gallic acid and sulfadimoxine. Its effect on osteoblast metabolism was investigated via the detection of cell proliferation, cell viability, production of ROS, and expression of osteogenic-specific genes including runt-related transcription factor 2 (RUNX2), bone sialoprotein (BSP), osteocalcin (OCN), alpha-1 type I collagen (COL1A1), and osteogenic-related proteins after treatment for 2, 4, and 6 days respectively. Results: The results showed that ZXHA-TC has a stimulating effect on the proliferation and osteogenic differentiation of primary osteoblasts by promoting cell proliferation, cell viability, and the expression of genes BSP and OCN. Productions of bone matrix and mineralization were also increased by ZXHA-TC treatment as a result of up-regulationof COL1A1 and alkaline phosphatase (ALP) at the early stage and down-regulationof both genes subsequently. A range of 6.25×10-3 μg/mL to 6.25×10-1 μg/mL is the recommended dose for ZXHA-TC, within which 6.25×10-2 μg/mL showed the best performance. Conclusion: This study may hold promise for the development of a novel agent for the treatment of osteoporosis.

Abstract

Purpose: This study is intended to investigate the effects of plants or plant-derived antioxidants on prevention of osteoporosis through the maintenance of reactive oxygenspecies (ROS) at a favorable level. Materials and Methods: In this study, a novel antioxidant, namely 3,4,5-Trihydroxy-N-[4-(5-hydroxy-6-methoxy-pyrimidin-4-ylsulfamoyl)-phenyl]-benzamide (ZXHA-TC) was synthesized from gallic acid and sulfadimoxine. Its effect on osteoblast metabolism was investigated via the detection of cell proliferation, cell viability, production of ROS, and expression of osteogenic-specific genes including runt-related transcription factor 2 (RUNX2), bone sialoprotein (BSP), osteocalcin (OCN), alpha-1 type I collagen (COL1A1), and osteogenic-related proteins after treatment for 2, 4, and 6 days respectively. Results: The results showed that ZXHA-TC has a stimulating effect on the proliferation and osteogenic differentiation of primary osteoblasts by promoting cell proliferation, cell viability, and the expression of genes BSP and OCN. Productions of bone matrix and mineralization were also increased by ZXHA-TC treatment as a result of up-regulationof COL1A1 and alkaline phosphatase (ALP) at the early stage and down-regulationof both genes subsequently. A range of 6.25×10-3 μg/mL to 6.25×10-1 μg/mL is the recommended dose for ZXHA-TC, within which 6.25×10-2 μg/mL showed the best performance. Conclusion: This study may hold promise for the development of a novel agent for the treatment of osteoporosis.

참고문헌 (40)

  1. Riggs BL, "Involutional osteoporosis", N Engl J Med, 314, pp.1676~1686 (1986)
  2. Simon LS, "Osteoporosis", Rheum Dis Clin North Am, 33, pp.149~176 (2007)
  3. Andersen SJ, "Osteoporosis in the older woman", Clin Obstet Gynecol, 50, pp.752~766 (2007)
  4. National Osteoporosis Foundation, "Clinician’s Guide to Prevention and Treatment of Osteoporosis", National Osteoporosis Foundation, ~ (2010)
  5. "Bone Health Basics: Get the Facts"[URL]
  6. National Osteoporosis Foundation, "Clinician’s Guide to Prevention and Treatment of Osteoporosis", National Osteoporosis Foundation, ~ (2013)
  7. Johnell O, "Advances in osteoporosis : better identification of risk factors can reduce morbidity and mortality", J Intern Med, 239, pp.299~304 (1996)
  8. Gold DT, "Osteoporosis and depression: a historical perspective", Curr Osteoporos Rep, 4, pp.134~139 (2006)
  9. Pereira JV, "Plant and plant-derived compounds employed in prevention of the osteoporosis", Acta Farm Bonaerense, 21, pp.223~234 (2002)
  10. Sharan K, "Role of phytochemicals in the prevention of menopausal bone loss: evidence from in vitro and in vivo, human interventional and pharma-cokinetic studies", Curr Med Chem, 16, pp.1138~1157 (2009)
  11. Arjmandi BH, "Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis", J Nutr, 126, pp.161~167 (1996)
  12. Ren P, "Protective effects of sodium daidzein sulfonate on trabecular bone in ovariectomized rats", Pharmacology, 79, pp.129~136 (2007)
  13. Kelly GE, "Treatment or prevention of osteoporosis", U.S. Patent 6,340,703, ~ (2002)
  14. Yadav DK, "Synthetic analogs of daidzein, having more potent osteoblast stimulating effect", Bioorg Med Chem Lett, 21, pp.677~681 (2011)
  15. Kuruto-Niwa R, "Effects of tea catechins on the ERE-regulated estrogenic activity", J Agric Food Chem, 48, pp.6355~6361 (2000)
  16. Shen CL, "Functions and mechanisms of green tea catechins in regulating bone remodeling", Curr Drug Targets, 14, pp.1619~1630 (2013)
  17. Lu Z, "Structure-activity relationship analysis of antioxidant ability and neuroprotective effect of gallic acid derivatives", Neurochem Int, 48, pp.263~274 (2006)
  18. Kroes BH, "Anti-inflammatory activity of gallic acid", Planta Med, 58, pp.499~504 (1992)
  19. Suntory Ltd, "High level expression of proteins in yeast", Patent 6,183,985, ~ (1995)
  20. Ou TT, "Gallic acid attenuates oleic acid-induced proliferation of vascular smooth muscle cell through regulation of AMPK-eNOS-FAS signaling", Curr Med Chem, 20, pp.3944~3953 (2013)
  21. Yoon CH, "Gallic acid, a natural polyphenolic acid, induces apoptosis and inhibits proinflammatory gene expressions in rheumatoid arthritis fibroblast-like synoviocytes", Joint Bone Spine, 80, pp.274~279 (2013)
  22. Chuang CY, "Gallic acid induces apoptosis of lung fibroblasts via a reactive oxygen species-dependent ataxia telangiectasia mutated-p53 activation pathway", J Agric Food Chem, 58, pp.2943~2951 (2010)
  23. Nuti E, "Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis : synthesis and biological evaluation", Eur J Med Chem, pp.379~394 (2013)
  24. Saxena HO, "Gallic acid-based indanone derivatives as anticancer agents", Bioorg Med Chem Lett, 18, pp.3914~3918 (2008)
  25. 강미선, "Effects of Methyl Gallate and Gallic Acid on the Production of Inflammatory Mediators Interleukin-6 and Interleukin-8 by Oral Epithelial Cells Stimulated with Fusobacterium nucleatum", The Journal of Microbiology, 47(6), pp.760~767 (2009), 한국미생물학회
  26. Ho HH, "Anti-metastasis effects of gallic acid on gastric cancer cells involves inhibition of NF-kappaB activity and downregulation of PI3K", AKT, Food Chem Toxicol, pp.2010, 48[DOI]
  27. Kuppan G, "Transcriptional regulation of cytokines and oxidative stress by gallic acid in human THP-1 monocytes", Cytokine, 49, pp.229~234 (2010)
  28. Lo C, "Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras", Melanoma Res, 21, pp.267~273 (2011)
  29. Schroeder TM, "Runx2: a master organizer of gene transcription in developing and maturing osteoblasts", Birth Defects Res C Embryo Today, 75, pp.213~225 (2005)
  30. Cobb J, "A mouse model for human short-stature syndromes identifies Shox2 as an upstream regulator of Runx2 during long-bone development", Proc Natl Acad Sci U S A, 103, pp.4511~4515 (2006)
  31. Liu W, "Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures", J Cell Biol, 155, pp.157~166 (2001)
  32. Na K, "Osteogenic differentiation of rabbit mesenchymal stem cells in thermo-reversible hydrogel constructs containing hydroxyapatite and bone morphogenic protein-2 (BMP-2)", Biomaterials, 28, pp.2631~2637 (2007)
  33. Stein GS, "Molecular mechanisms mediating proliferation", differentiation interrelationships during progressive development of the osteoblast phenotype, 1993, pp.14, 424~442
  34. D’Errico JA, "Expression of bone associated markers by tooth root lining cells, in situ and in vitro", Bone, 20, pp.117~126 (1997)
  35. Hakki SS, "Bone sialoprotein gene transfer to periodontal ligament cells may not be sufficient to promote mineralization in vitro or in vivo", J Periodontol, 77, pp.167~173 (2006)
  36. Hakki SS, "Effects of mineral trioxide aggregate on cell survival, gene expression associated with mineralized tissues, and biomineralization of cementoblasts", J Endod, 35, pp.513~519 (2009)
  37. Ducy P, "The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism", Diabetologia, 54, pp.1291~1297 (2011)
  38. Tielens S, "Effect of 17beta-estradiol on the in vitro differentiation of murine embryonic stem cells into the osteogenic lineage", In Vitro Cell Dev Biol Anim, 44, pp.368~378 (2008)
  39. zur Nieden NI, "In vitro differentiation of embryonic stem cells into mineralized osteoblasts", Differentiation, 71, pp.18~27 (2003)
  40. Sugisawa A, "Physiological concentrations of (-)-epigallocatechin-3-O-gallate (EGCg) prevent chromosomal damage induced by reactive oxygen species in WIL2-NS cells", J Nutr, 132, pp.1836~1839 (2002)

관련 논문AI추천

이 간행물의 다른 논문 (18건)